New York’s Department of Health is close to easing regulations for companies to make new products; and patients, their caretakers and providers to learn about medical marijuana.

But medical marijuana advocates say the DOH should prune more of the rules that have grown pot prices and stunted patient use since New York legalized the drug in 2014.

DOH officials countered that they’ll continue to make the medical cannabis program more accessible and affordable.

But the federal government’s pot prohibition - which prevents insurance coverage, makes the drug pricey.

Click here to read the complete article

Daniel Axelrod ~ Times Herald-Record ~